JF
COGT icon

Jump Financial’s Cogent Biosciences COGT Stock Holding History

Jump Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,326
Closed -$580K – 1965
2025
Q4 		$580K Buy
+16,326
New +$459K 0.01% 1250
2024
Q3 		– Sell
-37,695
Closed -$318K – 1702
2024
Q2 		$318K Buy
37,695
+27,170
+258% +$206K 0.01% 1353
2024
Q1 		$70.7K Sell
10,525
-14,493
-58% -$89.6K ﹤0.01% 1819
2023
Q4 		$147K Buy
+25,018
New +$192K ﹤0.01% 1619
2023
Q2 		– Sell
-24,400
Closed -$263K – 1853
2023
Q1 		$263K Sell
24,400
-22,302
-48% -$285K 0.01% 1177
2022
Q4 		$540K Sell
46,702
-998
-2% -$12.4K 0.03% 737
2022
Q3 		$712K Buy
+47,700
New +$654K 0.03% 754
2022
Q1 		– Sell
-16,200
Closed -$139K – 1595
2021
Q4 		$139K Buy
+16,200
New +$141K 0.01% 1173
2021
Q1 		– Sell
-18,122
Closed -$203K – 989
2020
Q4 		$203K Buy
+18,122
New +$199K 0.03% 780

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Jump Financial's COGT Position: Q1 2026 in Review

Jump Financial sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 16,326 shares — an estimated $580K sold.

Jump Financial first reported a position in COGT in Q4 2020 and held it in 9 quarters. The position peaked at $712K in Q3 2022. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Jump Financial reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 16,326 Cogent Biosciences shares in Q1 2026, an estimated $580K.
  • Jump Financial first reported a position in Cogent Biosciences in Q4 2020 and held it in 9 quarters.
  • Jump Financial's Cogent Biosciences position peaked at $712K in Q3 2022.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.